Buscar
01/01/2024
Acute kidney injury (AKI): Spanish nomenclature also matters here
Bover, J, Romero-González, G, Chávez-Iñiguez, JS, Rizo-Topete, L, Graterol, F, Santandreu, AV, Sanchez-Baya, M, Díaz, JM, Ortiz, A, Poch, YE. Acute kidney injury (AKI): Spanish nomenclature also matters here. NEFROLOGIA. 2024; 44(1)DOI:https://doi.org/10.1016/j.nefroe.2024.02.009. PMID:. IF:2.600(Q2/4D).
01/01/2024
Neurodesarrollo a los 2 años en cardiopatía congénita: utilidad pronóstica de los marcadores de daño cerebral
Vega Puyal L., Llurba E., Ferrer Q., Dolader Codina P., Sánchez García O., Montoliu Ruiz A., Sanchez-de-Toledo J.. Neurodesarrollo a los 2 años en cardiopatía congénita: utilidad pronóstica de los marcadores de daño cerebral. ANALES DE PEDIATRIA. 2024; 100(1)DOI:10.1016/j.anpedi.2023.10.007. PMID:38185573. IF:2.100(Q2/4D).
01/01/2024
Exploring the Effectiveness of Self-Management Interventions in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Tsokani, S, Seitidis, G, Christogiannis, C, Kontouli, KM, Nikolakopoulos, S, Zevgiti, S, Orrego, C, Ballester, M, Suñol, R, Heijmans, M, Poortvliet, R, van der Gaag, M, Alonso-Coello, P, Canelo-Aybar, C, Beltran, J, González-Gonzalez, AI, de Graaf, G, Veroniki, AA, Mavridis, D. Exploring the Effectiveness of Self-Management Interventions in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis. Healthcare. 2024; 12(1)DOI:10.3390/healthcare12010027. PMID:38200933. IF:2.700(Q2/4D).
01/01/2024
Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial
Perelló-Capó J., Estadella-Tarriel J., Gich-Saladich I., Bailón-Queiruga M., Llurba-Olivé E., Calaf-Alsina J.. Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial. CONTRACEPTION. 2024; 133DOI:10.1016/j.contraception.2024.110367. PMID:38232939. IF:2.300(Q2/4D).
01/01/2024
Key factors in the choice of appropriate outcomes for clinical trials
Cabrera-Ubilla, C, Nuñez-Galleguillos, V, Bracchiglione, J, Garnham, R, Pérez, I. Key factors in the choice of appropriate outcomes for clinical trials. Medwave. 2024; 24(4)DOI:10.5867/medwave.2024.04.2790. PMID:38748973. IF:(Q/D).
01/01/2024
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection
Arevalo-Rodriguez, I, Mateos-Haro, M, Dinnes, J, Ciapponi, A, Davenport, C, Buitrago-Garcia, D, Bennouna-Dalero, T, Roqué-Figuls, M, Van den Bruel, A, von Eije, KJ, Emperador, D, Hooft, L, Spijker, R, Leeflang, MMG, Takwoingi, Y, Deeks, JJ. Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection. COCHRANE DATABASE OF SYSTEMATIC REVIEWS. 2024; (10)DOI:10.1002/14651858.CD015618. PMID:39400904. IF:9.400(Q1/1D).
01/01/2024
Pilot evaluation of the ?Transformem els patis? program in elementary schools in Barcelona
Periañez, J, Continente, X, Sanz-Mas, M, Drou, G, Espelt, A, Cortés, E, López, MJ. Pilot evaluation of the ?Transformem els patis? program in elementary schools in Barcelona. Gaceta Sanitaria. 2024; 38DOI:10.1016/j.gaceta.2024.102429. PMID:39515025. IF:1.500(Q3/7D).
01/01/2024
Manejo integral de los factores de riesgo en enfermedad arterial periférica
Cuixart C.B., González P.B., Pelaez I.M., Ruiz D.S.. Manejo integral de los factores de riesgo en enfermedad arterial periférica. Fmc Formacion Medica Continuada En Atencion Primaria. 2024; 31(1)DOI:10.1016/j.fmc.2023.07.003. PMID:. IF:(Q/D).